Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Deloitte
Daiichi Sankyo
Colorcon
Johnson and Johnson
Merck
Harvard Business School
McKinsey
US Army

Generated: August 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018704

« Back to Dashboard

NDA 018704 describes LOPRESSOR, which is a drug marketed by Novartis and Us Pharms Holdings I and is included in four NDAs. It is available from three suppliers. Additional details are available on the LOPRESSOR profile page.

The generic ingredient in LOPRESSOR is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.
Summary for 018704
Tradename:LOPRESSOR
Applicant:Novartis
Ingredient:metoprolol tartrate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018704
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 018704
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LOPRESSOR metoprolol tartrate INJECTABLE;INJECTION 018704 NDA Novartis Pharmaceuticals Corporation 0078-0400 N 0078-0400-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/ML
Approval Date:Mar 30, 1984TE:APRLD:Yes

Expired US Patents for NDA 018704

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis LOPRESSOR metoprolol tartrate INJECTABLE;INJECTION 018704-001 Mar 30, 1984 ➤ Sign Up ➤ Sign Up
Novartis LOPRESSOR metoprolol tartrate INJECTABLE;INJECTION 018704-001 Mar 30, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
AstraZeneca
Queensland Health
QuintilesIMS
Boehringer Ingelheim
Express Scripts
Cerilliant
Argus Health
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.